Zobrazeno 1 - 5
of 5
pro vyhledávání: '"64"'
Autor:
Gerd Fabian Volk, Annegret Lorenz, Oliver Mothes, Carsten M. Klingner, Joachim Denzler, Farsin Hamzei, Luise Modersohn, Anika Steinerstauch, Orlando Guntinas-Lichius
Publikováno v:
Journal of Neurology. 266:46-56
Although central facial paresis (CFP) is a major symptom of stroke, there is a lack of studies on the motor and non-motor disabilities in stroke patients. A prospective cohort study was performed at admission for inpatient rehabilitation and discharg
Autor:
Massimiliano Calabrese, Eleonora Cocco, Roberta Fantozzi, Viviana Nociti, Antonio Gallo, Laura Boffa, Alice Laroni, Claudio Solaro, Valentina Torri Clerici, Giancarlo Coghe, Simona Malucchi, Massimiliano Di Filippo, Valentina Tomassini, Marcello Moccia, Pietro Annovazzi, Federica Pinardi, Carla Tortorella, Paola Cavalla, Ilaria Pesci, Luca Prosperini, Giorgia Teresa Maniscalco, Alberto Gajofatto, Claudio Gasperini, Roberta Lanzillo, Fabio Buttari, Paolo Ragonese, Marta Radaelli, Maria Chiara Buscarinu
Publikováno v:
Journal of neurology. 265(5)
In this independent, multicenter, retrospective study, we investigated the short-term persistence to treatment with first-line self-injectable or oral disease-modifying treatments (DMTs) in patients with relapsing–remitting multiple sclerosis. Data
Autor:
Eileen M. Joyce, Mark J. Edwards, Rachael Hunter, Glenn Nielsen, Lucia Ricciardi, Benedetta Demartini
Publikováno v:
Journal of Neurology. 262:674-681
Patients with functional motor disorder (FMD) are commonly seen by physiotherapists and there is growing evidence to support a physical rehabilitation approach. There are, however, few descriptions in the literature of the content of successful physi
Publikováno v:
Journal of neurology. 248(7)
The fear of “choking to death” is on the mind of most patients suffering from amyotrophic lateral sclerosis (ALS). So far, however, there have been no systematic surveys concerning the dying phase in a general ALS population. We therefore perform
Publikováno v:
Journal of Neurology
Patients who recover from aneurysmal subarachnoid haemorrhage (SAH) often remain disabled or have persisting symptoms with a reduced quality of life (QoL). We assessed functional outcome and QoL 5 and 12.5 years after SAH. In a consecutive series of